Evidence map›Paper›PMID 19638527›Full record

ReviewDiabetes care2009

Point: steady progress and current challenges in clinical islet transplantation.

Davide Mineo, Antonello Pileggi, Rodolfo Alejandro, Camillo Ricordi

Abstract readEditorialReview
In one paragraph

Review in Diabetes care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Re-engineering islet cell transplantation.Pharmacological research · 2015
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. 25 YEARS OF THE RICORDI AUTOMATED METHOD FOR ISLET ISOLATION.CellR4-- repair, replacement, regeneration, & reprogramming · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Davide Mineo
Antonello Pileggi
Rodolfo Alejandro
Camillo Ricordi

Funding

ISLET CELL RESOURCE FOR DIABETES RESEARCH AND TREATMENTU42RR016603 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2001 to 2009
$7.8M
USE OF OXANDROLONE TO IMPROVE FUNCTION IN CHRONIC SCIM01RR016587 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FLOREZ, HERMES · 2002 to 2005
$6.8M
PATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATIONR01DK056953 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2000 to 2004
$5.1M
NCRR NIH HHS M01 RR016587NCRR NIH HHS U42 RR016603NIDDK NIH HHS R01 DK056953
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell TransplantationC-PeptideDiabetes ComplicationsDiabetes Mellitus, Type 1HumansInsulin-Secreting CellsIslets of Langerhans TransplantationTreatment OutcomeC-Peptide

Identifiers

PMID19638527
PMCPMC2713646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.